NCT01835847

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

Tipepidine for Adolescent Depression

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Chiba University · Academic / Other
• Sex: All
• Age: 10 Years – 18 Years
• Healthy volunteers: Not accepted

Summary

Accumulating evidence suggests a role of G protein-coupled inwardly-rectifying potassium (GIRK) channel in the pathology of excitement of nerve, and the medicine with the action (like the Tipepidine Hibenzate) is expected as a new curative medicine of adolescent depression. The purpose of this research is to confirm the effect by carrying out the additional dosage of the Tipepidine Hibenzate to the adolescent patients with depression. If suggestion is obtained by this research about the effect on adolescent patients with depression of Tipepidine Hibenzate, it can contribute to development of the medical treatment of adolescent patients with depression.

Conditions

• Depression
• Adolescent

Interventions

Type	Name	Description
DRUG	Tipepidine Hibenzate

Timeline

• Start date: 2013-04-01
• Primary completion: 2014-02-01
• Completion: 2014-03-01
• First posted: 2013-04-19
• Last updated: 2014-05-23

Locations

1 site across 1 country: Japan